Clinical Trial: A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Study Status: Completed
Recruit Status: RECRUITING
Condition: Wilms Tumor
Study Type: INTERVENTIONAL
Official Title: A Multi-Center Phase II Study of Selinexor in Treating Recurrent or Refractory Wilms Tumor and Other Pediatric Solid Tumors
Brief Summary:
The purpose of this study is to find out whether selinexor is an effective treatment for people under the age of 51 who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, or another solid tumor that makes a higher than normal amount of XPO1 or has genetic changes that increase the activity of XP01.
Read more